ZBIO vs. HOOD
Compare and contrast key facts about Zenas BioPharma, Inc (ZBIO) and Robinhood Markets, Inc. (HOOD).
Performance
ZBIO vs. HOOD - Performance Comparison
Loading graphics...
ZBIO vs. HOOD - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | |
|---|---|---|---|
ZBIO Zenas BioPharma, Inc | -43.93% | 343.35% | -54.88% |
HOOD Robinhood Markets, Inc. | -38.01% | 203.54% | 68.83% |
Fundamentals
ZBIO:
-$4.52
HOOD:
$2.06
ZBIO:
57.02
HOOD:
17.81
ZBIO:
$15.00M
HOOD:
$3.60B
ZBIO:
-$33.03M
HOOD:
$2.69B
ZBIO:
-$195.98M
HOOD:
$1.51B
Returns By Period
In the year-to-date period, ZBIO achieves a -43.93% return, which is significantly lower than HOOD's -38.01% return.
ZBIO
- 1D
- 4.14%
- 1M
- -20.34%
- YTD
- -43.93%
- 6M
- -7.96%
- 1Y
- 167.89%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
HOOD
- 1D
- 1.17%
- 1M
- -11.01%
- YTD
- -38.01%
- 6M
- -49.61%
- 1Y
- 66.30%
- 3Y*
- 93.28%
- 5Y*
- —
- 10Y*
- —
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ZBIO vs. HOOD — Risk / Return Rank
ZBIO
HOOD
ZBIO vs. HOOD - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Zenas BioPharma, Inc (ZBIO) and Robinhood Markets, Inc. (HOOD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| ZBIO | HOOD | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.42 | 0.94 | +0.48 |
Sortino ratioReturn per unit of downside risk | 2.15 | 1.69 | +0.46 |
Omega ratioGain probability vs. loss probability | 1.32 | 1.20 | +0.12 |
Calmar ratioReturn relative to maximum drawdown | 2.43 | 1.20 | +1.24 |
Martin ratioReturn relative to average drawdown | 6.10 | 2.89 | +3.21 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| ZBIO | HOOD | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.42 | 0.94 | +0.48 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.07 | 0.22 | -0.15 |
Correlation
The correlation between ZBIO and HOOD is 0.23, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
ZBIO vs. HOOD - Dividend Comparison
Neither ZBIO nor HOOD has paid dividends to shareholders.
Drawdowns
ZBIO vs. HOOD - Drawdown Comparison
The maximum ZBIO drawdown since its inception was -74.96%, smaller than the maximum HOOD drawdown of -90.21%. Use the drawdown chart below to compare losses from any high point for ZBIO and HOOD.
Loading graphics...
Drawdown Indicators
| ZBIO | HOOD | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -74.96% | -90.21% | +15.25% |
Max Drawdown (1Y)Largest decline over 1 year | -64.79% | -57.26% | -7.53% |
Current DrawdownCurrent decline from peak | -52.84% | -54.01% | +1.17% |
Average DrawdownAverage peak-to-trough decline | -41.27% | -61.46% | +20.19% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 25.85% | 23.68% | +2.17% |
Volatility
ZBIO vs. HOOD - Volatility Comparison
Zenas BioPharma, Inc (ZBIO) has a higher volatility of 25.22% compared to Robinhood Markets, Inc. (HOOD) at 17.83%. This indicates that ZBIO's price experiences larger fluctuations and is considered to be riskier than HOOD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| ZBIO | HOOD | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 25.22% | 17.83% | +7.39% |
Volatility (6M)Calculated over the trailing 6-month period | 105.17% | 49.80% | +55.37% |
Volatility (1Y)Calculated over the trailing 1-year period | 119.39% | 71.27% | +48.12% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 112.11% | 73.92% | +38.19% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 112.11% | 73.92% | +38.19% |
Financials
ZBIO vs. HOOD - Financials Comparison
This section allows you to compare key financial metrics between Zenas BioPharma, Inc and Robinhood Markets, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities